Select Page
Responsive Centered YouTube Video
Investigation into lasting effects of COVID-19 vaccine spike protein in circulation.
  • Research focused on spike protein circulation post-vaccination and antibody response. 1:09

  • Dr. Carlo Brogna and George M. Gash leading the discussion on their findings. 2:03

  • Study aimed to understand spike protein persistence and impact on immunity. 3:07

  • Importance of determining spike protein half-life for vaccine effectiveness. 5:33

  • Ongoing research to further investigate spike protein presence after six months. 7:08

  • Initial results showed spike protein detected in 50% of vaccinated individuals. 7:18

  • Discussion on potential implications of spike protein presence independent of antibody levels. 7:33

  • Challenges of extrapolating findings from small-scale study with 20 participants. 7:42

Study on the duration of circulating spike protein after mRNA vaccination and its implications.
  • Study focused on medical doctors administering mRNA vaccines 8:39

  • Challenges in recruiting participants due to low vaccination rates in Italy 8:57

  • Method developed towards the end of the pandemic limiting participation to 20 doctors 9:38

  • Differentiating spike protein from vaccine vs infection using proteomic methods 11:13

  • Some individuals had circulating spike protein without generating antibodies 13:08

  • Duration of circulating spike protein studied up to six months post double mRNA dose 14:55

  • Mechanisms of circulating spike protein discussed with three potential ideas 15:33

Discussion on the potential integration of spike protein, bacterial involvement, and antibody response.
  • Testing hypotheses on spike protein integration, production, and bacterial involvement. 15:41

  • Plan to reevaluate spike protein presence in cells after two years. 16:32

  • Investigating bacterial production of spike protein post-vaccination. 17:11

  • Consideration of extracellular vesicles containing spike protein affecting antibody response. 18:23

  • Exploration of potential bacterial role in spike protein production and immune response. 19:28

  • Observation of disbiosis similarities in vaccine-injured and Long Covid patients. 21:45

  • Need for further research on mechanisms linking bacteria, spike protein, and immune response. 22:11

Discussion on the potential implications of prolonged spike protein production post-vaccination.
  • Patients treated with specific antibiotics show no long covid symptoms. 23:01

  • Microbiome may play a crucial role in preventing long covid conditions. 23:23

  • Concerns raised about the misinformation regarding persistent spike protein production. 26:01

  • Research suggests presence of spike protein fragments in gut epithelium post-infection. 27:33

  • Speculation on the source of prolonged spike protein production, possibly immune cells or bacteria. 28:13

  • Identification of spike protein sequences in the gut epithelium post-degradation. 29:08

Significance of continued presence of Spike protein post-vaccination and implications on human cells.
  • Detection of specific epitope indicates ongoing Spike protein production post-vaccination. 29:25

  • Presence of Spike protein in serum suggests deposition in cells, posing a warning sign. 29:53

  • Free-floating Spike protein in blood implies higher amount deposited in cells. 34:18

  • Spike protein has high affinity to fuse with cell membranes and receptors. 34:50

  • Hypothesis involving line one and retroviruses may be linked to presence of Spike protein in human cells. 35:04

Potential dangers of ongoing circulation of spike protein and implications on autoimmune diseases.
  • Spike protein integration into DNA and SV40 promoter assisting integration into cells. 35:12

  • Spike protein can cause harm in the body, leading to various health issues. 36:02

  • Presence of circulating spike protein may drive autoimmune diseases over time. 38:29

  • Autoimmune state development in long-haulers with prolonged exposure to spike proteins. 39:37

  • Autoantibodies attacking own cells, especially in the central nervous system. 39:53

  • Some individuals experiencing autoimmune-driven symptoms like ALS, leading to unpleasant outcomes. 40:07

  • Challenges in addressing autoimmune issues arising from prolonged exposure to spike protein. 40:24

  • Importance of understanding and addressing consequences of spike protein circulation. 40:35

Significant concerns regarding microclotting and autoimmune response in long haulers and vaccinated individuals.
  • Identification of at-risk individuals is challenging due to lack of clear markers for long COVID and vaccine injuries. 41:07

  • Markers such as TGF beta and neurological proteins like GFAP and amyloid beta 40/42 ratios are prevalent in long haulers. 42:25

  • Microclotting observed under fluorescent microscopy is becoming increasingly common, indicating a serious issue. 44:13

  • The combination of a highly infectious variant triggering an autoimmune response poses a significant challenge. 45:26

  • Primary pathophysiology of microclotting needs to be understood to address the issue effectively. 46:07

  • Caution advised against using triple anticoagulation without a clear understanding of the underlying mechanisms. 46:13

  • Flying blind in addressing microclotting without a complete understanding of the situation. 46:39

Significance of Persistent Spike Protein in COVID-19 Recovery.
  • Spike protein in endothelial cells leads to inflammation and coagulation cascade. 46:58

  • Removing spike protein from cells is crucial for recovery. 47:32

  • Differentiating between productive and unproductive persistence of spike protein. 48:50

  • Need to bind and remove spike protein safely to prevent further harm. 50:03

  • Complexity of the issue requires scientific community’s attention for solutions. 50:41

  • Focus should be on mitigating impact and protecting individuals from severe outcomes. 51:39

  • Urgent need for medical authorities to acknowledge and act on groundbreaking research findings. 52:22

Discussion on the challenges faced by the scientific and medical community during the COVID-19 pandemic.
  • Lack of understanding in hospitals regarding effective treatments for COVID-19 patients. 53:09

  • Importance of utilizing H1 H2 blocker and Montoluucas to avoid patients being put on respirators. 53:34

  • Criticism towards the medical community for not heeding advice from experts with proven success in treating COVID-19. 53:42

  • Call for a reevaluation of interventions and strategies to control the spread of the virus. 54:13

  • Acknowledgment of the challenging times and the necessity to make a difference in combating the pandemic. 54:47

  • Appreciation for research and developments aimed at helping people during the crisis. 55:10

  • Wishing Merry Christmas to all viewers and expressing gratitude for their support. 55:16

  • Closure of the discussion with thanks and well wishes. 55:24